# Hypertension and alcohol: a cross-sectional study comparing PEth with AUDIT and AUDIT-C in primary care

**Authors:** Åsa Thurfjell, Maria Hagströmer, Charlotte Ivarsson, Anders Norrman, Johanna Adami, Lena Lundh, Jan Hasselström

PMC · DOI: 10.1093/fampra/cmaf097 · Family Practice · 2026-01-09

## TL;DR

This study compares different methods to detect alcohol use in hypertensive patients and finds that PEth and AUDIT-C are more effective than AUDIT in identifying alcohol-related issues.

## Contribution

The study introduces PEth as a more effective biomarker for detecting alcohol use in patients with treatment-resistant hypertension compared to traditional screening tools.

## Key findings

- PEth detected significantly higher alcohol use in patients with apparent treatment-resistant hypertension.
- AUDIT-C identified more hazardous alcohol use than AUDIT across all blood pressure groups.
- PEth correlated more strongly with AUDIT-C than with AUDIT, suggesting better alignment in alcohol use detection.

## Abstract

This cross-sectional study aimed to describe proportions of patients with indications of alcohol consumption using phosphatidylethanol (PEth), the Alcohol Use Disorders Identification Test (AUDIT), and its consumption-focused version (AUDIT-C), in relation to blood pressure (BP) control, overall and by sex.

A total of 270 hypertensive primary care patients (ICD-10: I10.9) were stratified into BP control groups: controlled (<140/90 mmHg), uncontrolled (≥140/90 mmHg), and apparent treatment-resistant hypertension (aTRH; ≥140/90 mmHg with ≥3 antihypertensive drugs). A randomized sample from each stratum was invited, baseline data were collected. Alcohol consumption using predefined categories for PEth and AUDIT, and hazardous use (PEth ≥ 0.122 µmol/L; AUDIT ≥ 8; AUDIT-C ≥ 5 for men, ≥4 for women), were analyzed in relation to BP control groups.

Mean age was 67 ± 11 years; 42% were women. PEth indicated high and regular alcohol consumption in 6.4% of controlled, 5.3% of uncontrolled, and 19.2% of aTRH patients (controlled vs. aTRH, P = .027; uncontrolled vs. aTRH, P = .013). AUDIT showed no significant differences in hazardous use between BP groups (P = .865). AUDIT-C identified slightly higher proportions of hazardous use than PEth, across BP groups and sexes. No significant differences were found between BP groups for hazardous use by PEth (P = .339) or AUDIT-C (P = .150).

PEth revealed significantly higher alcohol use in the aTRH group, undetected by AUDIT. AUDIT-C and PEth identified more hazardous use than AUDIT, suggesting their potential to prompt alcohol-related discussions and support evidence-based hypertension care. PEth correlated more strongly with AUDIT-C than with AUDIT.

Retrospectively registered in Clinical Trials, SLSO2022-0143, 2022-12-10.

## Full-text entities

- **Diseases:** Hypertension (MESH:D006973), Alcohol Use Disorders (MESH:D000437)
- **Chemicals:** PEth (MESH:C051521), Alcohol (MESH:D000438)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12787009/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12787009/full.md

## References

54 references — full list in the complete paper: https://tomesphere.com/paper/PMC12787009/full.md

---
Source: https://tomesphere.com/paper/PMC12787009